Serial #79309395
LIVE

Serial Number

79309395

Owner

Goryo Chemical, Inc.

Attorney

Mary Margaret L. O'Donnell

Filing Date

Dec 21, 2020

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79309395 Trademark

Serial Number: 79309395 • Registration: 6696150

Serial #79309395 is a trademark filed by Goryo Chemical, Inc. on December 21, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Goryo Chemical, Inc. (3 trademarks)

EAREE Bldg. 5F,
Sapporo-shi, Hokkaido 060-0008 , JP

Entity Type: 03

Trademark Details

Filing Date

December 21, 2020

Registration Date

April 12, 2022

Published for Opposition

January 25, 2022

Goods & Services

Medical testing services using fluorescent reagents for diagnostic or treatment purposes; medical analysis services for the analysis, diagnosis, and treatment of patients using fluorescent reagents provided by medical laboratories; medical analysis for the diagnosis and treatment of persons; medical diagnostic services; medical evaluation of breast, brain, colorectal and gastro-intestinal cancer; medical diagnostic services using fluorescent reagents; medical evaluation services of breast, brain, colorectal and gastro-intestinal cancer using fluorescent reagents; diagnosis of diseases; diagnosis of diseases using fluorescent reagents; diagnosis of cancer; diagnosis of cancer using fluorescent reagents; medical testing services relating to the diagnosis and treatment of disease; medical testing services relating to the diagnosis and treatment of disease using fluorescent reagents; medical analysis services relating to the diagnosis and treatment of disease using fluorescent reagents provided by medical laboratories; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis for the diagnosis of cancer; cancer screening services; cancer screening services using fluorescent reagents; medical services for the analysis of samples taken from patients provided by medical laboratories; fluorescence imaging examination for the medical diagnosis or treatment; providing information in the field of cancer prevention, screening, diagnosis and treatment; providing medical information; providing medical information on diagnosis using fluorescent reagents; providing information on medical diagnosis using fluorescent reagents; medical analysis for the diagnosis of cancer using fluorescent reagents; rental of medical apparatus and installations; rental of medical diagnostic apparatus and installations; rental of medical diagnostic apparatus using fluorescent reagents and medical apparatus and installations using fluorescent reagents; rental of medical measuring apparatus

Pharmaceutical preparations and substances for the diagnosis and treatment, and the prevention of breast, brain, colorectal and gastro-intestinal cancer; pharmaceutical preparations and substances used for detecting body fluids; pharmaceutical preparations and substances used for detecting pancreatic fluids; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of cancer; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of digestive system disorders; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of bone diseases; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of hyperlipidemia diseases; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of gastrointestinal diseases; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of hypoglycemia; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of sarcoma; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of immune system diseases and disorders; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of hypertension; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of respiratory diseases and disorders; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of skin disorders; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of multiple sclerosis; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of cardiovascular diseases; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for treating central nervous system disorders; diagnostic biomarker reagents for medical purposes; veterinary diagnostic reagents; fluorescent diagnostic reagents for veterinary purposes; fluorescent diagnostic test reagents for veterinary purposes; diagnostic test reagents for medical purposes; fluorescent diagnostic test reagents for medical purposes; fluorescent diagnostic reagents for medical purposes; pharmaceutical preparations and other preparations for destroying vermin, fungicides, herbicides; fluorescent tracer agent for medical diagnostics or veterinary purposes; chemical reagents for veterinary purposes; fluorescent chemical reagents for veterinary purposes; chemical reagents for medical purposes; fluorescent chemical reagents for medical purposes; reagents for medical purposes; fluorescent reagents for medical purposes; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic reagents and analysis samples for testing of body fluids; medical fluorescent diagnostic reagents and assays for testing of body fluids; medical fluorescent diagnostic reagents and analysis samples for testing of body fluids; medical clinical diagnostic reagents; fluorescent reagents for the clinical diagnosis; therapeutic drugs and agents, namely, agents for the treatment of malignant tumors

Reagents for research purposes; reagents for chemical analyses other than for medical or veterinary purposes; reagents for use in scientific apparatus for chemical or biological analysis; diagnostic reagents for scientific or research use; diagnostic reagents and preparations, except for medical or veterinary use; chemicals, namely, chemicals used in industry, sulfonates, chemicals for use in agriculture, except fungicides, herbicides, insecticides and parasiticides

Filing History

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
May 2, 2023 NURC
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 28, 2023 APRE
CORRECTION UNDER SECTION 7 - PROCESSED
Mar 28, 2023 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 23, 2023 APRE
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 20, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 29, 2022 FICS
FINAL DISPOSITION PROCESSED
Aug 29, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 12, 2022 FICR
TEAS SECTION 7 REQUEST RECEIVED
Jul 7, 2022 ES7R
REGISTERED-PRINCIPAL REGISTER
Apr 12, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Jan 30, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 25, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jan 25, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 5, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 5, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 5, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 23, 2021 CNSA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 21, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 21, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 21, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 21, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 21, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 21, 2021 COAR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 21, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 21, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 21, 2021 TROA
REFUSAL PROCESSED BY IB
Aug 1, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 12, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jul 12, 2021 RFRR
NEW REPRESENTATIVE AT IB RECEIVED
Jul 3, 2021 NREP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 25, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jun 24, 2021 CNRT
ASSIGNED TO EXAMINER
Jun 16, 2021 DOCK
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
May 19, 2021 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
May 16, 2021 CRCV
APPLICATION FILING RECEIPT MAILED
Apr 27, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 23, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 22, 2021 REPR